Low rates of antibiotic use among ambulatory patients with coronavirus disease 2019 (COVID-19).

Alison G C Smith Eli P Wilber Paulina A Rebolledo Joseph SharpSheetal KandiahDaniel S Graciaa Russell R Kempker

Published in: Antimicrobial stewardship & healthcare epidemiology : ASHE (2022)

We assessed the prevalence of antibiotic prescriptions among ambulatory patients tested for coronavirus disease 2019 (COVID-19) in a large public US healthcare system and found a low overall rate of antibiotic prescriptions (6.7%). Only 3.8% of positive severe acute respiratory coronavirus virus 2 (SARS-CoV-2) tests were associated with an antibiotic prescription within 7 days.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
blood pressure
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
healthcare
prognostic factors
risk factors
peritoneal dialysis
adverse drug